Management of advanced basal cell carcinoma: Real‐life data with sonidegib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Management of advanced basal cell carcinoma: Real‐life data with sonidegib

Published:2021-03-23 Issue:3 Volume:34 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Moscarella Elvira¹^ORCID,Brancaccio Gabriella¹,Briatico Giulia¹^ORCID,Ronchi Andrea²,Verolino Pasquale³,Argenziano Giuseppe¹,Alfano Roberto⁴

Affiliation:

1. Dermatology Unit University of Campania Luigi Vanvitelli Naples Italy

2. Pathology Unit, Department of Mental and Physical Health and Preventive Medicine University of Campania Luigi Vanvitelli Naples Italy

3. Plastic Surgery Unit, Multidisciplinary Department of Medical‐Surgical and Dental Specialties University of Campania Luigi Vanvitelli Naples Italy

4. Department of Anesthesiology, Surgery and Emergency University of Campania Luigi Vanvitelli Naples Italy

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.14948

Reference8 articles.

1. Basal cell carcinoma

2. Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial

3. Sonidegib for the treatment of advanced basal cell carcinoma: a comprehensive review of sonidegib and the BOLT trial with 12-month update

4. Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind BOLT study

5. Complete remission of an advanced basal cell carcinoma after only 3‐month treatment with sonidegib: Report of a case and drug management during COVID ‐19 pandemic

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on the current and emerging pharmacotherapies for basal cell carcinomas;Expert Opinion on Pharmacotherapy;2023-11-18

2. Sonidegib in Locally Advanced Basal Cell Carcinoma: A Monocentric Retrospective Experience and a Review of Published Real-Life Data;Cancers;2023-07-14

3. Efficacy and safety of sonidegib for the management of basal cell carcinoma: a drug safety evaluation;Expert Opinion on Drug Safety;2023-06-20

4. Locally advanced basal cell carcinoma: Real‐life data with sonidegib;Dermatologic Therapy;2022-03-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3